You can buy or sell BASI and other stocks, options, ETFs, and crypto commission-free!
Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Contract Research Services and Research Products. Read More The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.
West Lafayette, Indiana
52 Week High
52 Week Low
Yahoo FinanceMay 1
The Smithers Avanza Toxicology Services Business Unit Acquired by Bioanalytical Systems, Inc. “BASi”
AKRON, Ohio--(BUSINESS WIRE)-- The Smithers Avanza Toxicology Services business unit in Gaithersburg, MD, a boutique contract research organization (CRO) specializing in general toxicology, vaccine safety and developmental and reproductive toxicology (DART), announced today that it will be acquired by Bioanalytical Systems, Inc. (BASI) (“BASi” or the “Company”). The Smithers Avanza Bioanalytical Services business is not included in this sale. “Selling a business unit is never an easy decision, but we reco...
-$0.06 per share